─ Alma by ResQ Medical
Every life matters.Every minute counts.
ResQ Medical has completed a feasibility study with no device-related adverse events. The pivotal study is now enrolling, FDA IDE is approved, and commercial preparation is underway.
FDA IDE approved
Pivotal enrolling
Commercial preparation
Commercial preparation
underway
The Need —replace second bullet
Balloon-based devices work against the body’s natural contraction mechanism and carry a meaningful risk of failure. The category is moving toward low-vacuum technology and the market is ready for the next generation: stronger performance, simpler use, and reliable anti-clogging operation.
The Need —replace second bullet
Balloon-based devices work against the body’s natural contraction mechanism and carry a meaningful risk of failure. The category is moving toward low-vacuum technology and the market is ready for the next generation: stronger performance, simpler use, and reliable anti-clogging operation.
The Need —replace second bullet
Balloon-based devices work against the body’s natural contraction mechanism and carry a meaningful risk of failure. The category is moving toward low-vacuum technology and the market is ready for the next generation: stronger performance, simpler use, and reliable anti-clogging operation.